# RATIO: Rational Approach To Immuno-Oncology

> **NCT02700971** · NA · COMPLETED · sponsor: **AHS Cancer Control Alberta** · enrollment: 35 (actual)

## Conditions studied

- Metastatic Melanoma

## Interventions

- **PROCEDURE:** Molecular Microscope Diagnostic system

## Key facts

- **NCT ID:** NCT02700971
- **Lead sponsor:** AHS Cancer Control Alberta
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-06-23
- **Primary completion:** 2022-06-01
- **Final completion:** 2023-09-08
- **Target enrollment:** 35 (ACTUAL)
- **Last updated:** 2024-06-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02700971

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02700971, "RATIO: Rational Approach To Immuno-Oncology". Retrieved via AI Analytics 2026-06-07 from https://api.ai-analytics.org/clinical/NCT02700971. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*